Successful management of thrombotic thrombocytopenic purpura in a Jehovah's Witness without plasma exchange | Zendy

Chai Wanxing | Zendy; Chaudhry Abrar | Zendy; Rabinowitz Arthur P. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Successful management of thrombotic thrombocytopenic purpura in a Jehovah's Witness without plasma exchange

Author(s) -

Chai Wanxing,

Chaudhry Abrar,

Rabinowitz Arthur P.

Publication year - 2015

Publication title -

journal of clinical apheresis

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.697

H-Index - 46

eISSN - 1098-1101

pISSN - 0733-2459

DOI - 10.1002/jca.21325

Subject(s) - thrombotic thrombocytopenic purpura , medicine , microangiopathic hemolytic anemia , apheresis , therapeutic plasma exchange , plasmapheresis , plateletpheresis , exchange transfusion , fresh frozen plasma , blood transfusion , purpura (gastropod) , thrombotic microangiopathy , platelet , surgery , immunology , antibody , disease , ecology , biology

Thrombotic thrombocytopenic purpura (TTP) is a hematologic emergency characterized by microangiopathic hemolytic anemia and thrombocytopenia. Plasma exchange is the standard treatment. Treating TTP without plasma exchange is a challenge. Due to religious beliefs, Jehovah's Witnesses do not accept transfusions of blood products. We report a case of successful treatment of TTP in a Jehovah's Witness using plasma exchange with albumin replacement. J. Clin. Apheresis 30:46–49, 2015. © 2014 Wiley Periodicals, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research